+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diagnostic Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • PDF Icon


  • 115 Pages
  • April 2023
  • Region: Global
  • Mordor Intelligence
  • ID: 4591659
The diagnostic imaging market is expected to register a CAGR of nearly 6.1% during the forecast period.

The COVID-19 pandemic was expected to have a significant impact on the market. According to an article published in European Radiology in November 2020, chest radiography was useful in identifying COVID-19 patients who may rapidly deteriorate and helping inform clinical management and hospital bed and ventilation allocation. This increased the demand for chest radiography during the pandemic phase. Similarly, in April 2020, the National COVID-19 Chest Imaging Database (NCCID) was launched in the United Kingdom, which provides a more comprehensive understanding of COVID-19 by collating X-rays, CT, and MRI scan data from 20 NHS trusts across the country to detect disease patterns and markers of the virus using Artificial Intelligence (AI), which, in turn, enabled more accurate early diagnoses and prognoses. This is expected to boost the demand for such equipment and tests during the COVID-19 pandemic. In addition, the demand for diagnostic imaging is expected to remain constant due to the reopening of diagnostic clinics and hospitals with high patient inflow, thereby contributing to the growth of the market over the coming five years.

The main things that are driving the growth of the diagnostic imaging market are the increase in chronic diseases, the rise in the number of older people, and the use of more advanced imaging technologies.

The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases, thereby contributing to the growth of the market. According to GLOBOCAN, in 2020, about 19.3 million new cases of cancer were reported worldwide, and this number is expected to increase to 30.2 million in 2040. Such an increase in cancer cases is expected to contribute to the growth of the market over the forecast period. Similarly, the British Heart Foundation data published in January 2022 reported that the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million), and atrial fibrillation (60 million). Such a large prevalence globally is fueling the growth of the market.

Additionally, the increasing number of product launches is expected to contribute to the growth of the market. For instance, in March 2021, Hitachi Medical Systems launched two permanent open MRI systems, APERTO Lucent Plus and AIRIS Vento Plus, at the start of the 2021 European Congress of Radiology. Both systems are equipped with SynergyDrive workflow solutions.

Thus, the above-mentioned factors are expected to contribute to the growth of the market over the forecast period.

Diagnostic Imaging Market Trends

Mid-range Scanners (~64-Slice) Segment under Computed Tomography expected to Account for Largest Market Share during the Forecast Period

Mild-range scanners are expected to hold a significant share in the growth of the market over the forecast period. Companies took several definite measures in order to keep up with the growing demand for scanners all over the world. Mid-range CT scanners are better for performing angiography in comparison with low-range CT scanners. Its characteristics, such as high speed and sensitivity, allow healthcare professionals to view the walls of arteries for plaque formation and to observe the tiniest of vessels and arterial branches, making it well suited for cardiac studies.

To grow their presence in the market, companies are continuously engaged in the development of new products, which in turn contributes to the growth of the segment. For instance, in January 2020, Allergen, in collaboration with Canon Medical Systems Corporation, introduced a new CT scanner in the market, the ACUTOM 32, which is a 32-slice CT scanner featuring a wide bore gantry of 32 cm, about a 2.0 MHU X-ray tube, and about 0.75 seconds of rotation time. Similarly, in January 2022, the Port Perry Hospital Foundation (PPHF) surpassed its goal of raising USD 4 million to bring a CT scanner and other essential equipment to the Scugog healthcare center. In February 2020, Samsung NeuroLogica made more of its 32-slice CT scanner, the mobile BodyTom, because COVID-19 cases were rising quickly.It allows scanning of COVID-19 patients at the point of care due to its internally shielded design and, at the same time, minimizes exposure to the virus. Because of this, the segment being studied is expected to grow over the next few years.

So, the growth of the market is likely to be fueled by the release of more CT scanners.

North America is Expected to Dominate the Market Over the Forecast Period

North America was found to hold a major share of the diagnostic imaging market and is expected to show a similar trend over the forecast period. This is mainly due to the rising prevalence of chronic diseases and the high demand for advanced diagnostic imaging.

The United States contributes the largest share of the diagnostic imaging market, which can be attributed to increasing technological advances, higher affordability rates among the population, and an increase in the number of diagnostic procedures each year.Furthermore, the market is expected to grow during the forecast period due to the presence of well-established healthcare facilities, rising demand for advanced healthcare systems among the aging population, and the rising prevalence of chronic diseases.For instance, the data published by the American Cancer Society in 2022 mentioned that a total of 1.9 million new cancer cases are expected to occur in the United States in 2022. Also, the growing number of neurological disorders such as brain tumors is expected to propel market growth. As per the American Cancer Society Journal article published in 2022, in 2021, an estimated 83,750 individuals were diagnosed with brain and other central nervous system tumors in the United States.

Also, the increasing number of product launches is expected to contribute to the growth of the market over the forecast period. For instance, in December 2021, Fujifilm Healthcare launched the Velocity MRI system, its advanced, high-field open MRI, during the 2021 Radiological Society of North America conference in Chicago.

Because of all of these things, the market is expected to grow in this region over the next few years.

Diagnostic Imaging Market Competitor Analysis

The market studied is fragmented owing to the presence of several players in the market. The competitive landscape includes an analysis of a few international as well as local companies that hold large market shares and are well known. Siemen Healthcare, Koninklijke Philips NV, GE Healthcare, Hologic Corporation, and Mindray Medical International Limited are some of the most important companies in the market.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition?
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
4.2.3 Increase in the Geriatric Population
4.3 Market Restraints
4.3.1 Expensive Procedures and Equipment
4.3.2 Side Effects of Diagnostic Imaging
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Modality
5.1.1 MRI Low and mid field MRI Systems (less than 1.5 T) High field MRI Systems (1.5-3 T) Very High and Ultra High Field MRI Systems (3T and more)
5.1.2 Computed Tomography Low-end Scanners (~16-Slice) Mid-range Scanners (~64-Slice) High-end Scanners (128-Slice and More)
5.1.3 Ultrasound 2D Ultrasound 3D Ultrasound Other Ultrasound
5.1.4 X-Ray Analog Systems Digital Systems
5.1.5 Nuclear Imaging Positron Emission Tomography (PET) Single Photon Emission Computed Tomography (SPECT)
5.1.6 Fluoroscopy
5.1.7 Mammography
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Gastroenterology
5.2.6 Gynecology
5.2.7 Other Applications
5.3 By End User
5.3.1 Hospital
5.3.2 Diagnostic Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Esaote SpA
6.1.3 FUJIFILM Holdings Corporation
6.1.4 GE Healthcare
6.1.5 Hologic Corporation
6.1.6 Koninklijke Philips NV
6.1.7 Shimadzu Medical
6.1.8 Siemens Healthineers
6.1.9 Mindray Medical International Limited
6.1.10 Browns Medical Imaging (BMI)
6.1.11 Samsung Electronics Co. Ltd
6.1.12 Koning Corporation

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Canon Medical Systems Corporation
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hologic Corporation
  • Koninklijke Philips NV
  • Shimadzu Medical
  • Siemens Healthineers
  • Mindray Medical International Limited
  • Browns Medical Imaging (BMI)
  • Samsung Electronics Co. Ltd
  • Koning Corporation